SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001075970-08-000012
Filing Date
2008-06-05
Accepted
2008-06-05 13:52:50
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3337
  Complete submission text file 0001075970-08-000012.txt   5427
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Issuer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1

Mailing Address C/O NUTRACEUTICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL PARK CITY UT 84060
Business Address C/O NUTREACUTICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL PARK CITY UT 84060 4356556000
BENSON GREGORY M (Reporting) CIK: 0001075970 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23731 | Film No.: 08882601